Back to UBS Group AG UBS Group AG

ATXIATXI
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in Avenue Therapeutics, Inc.

UBS Group AG previously held 0 shares of ATXI (Avenue Therapeutics, Inc.), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$2,356

Total Shares Change

-673

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$0.31
0
2024-Q4
Increased
7,920
+28.9%
$15,8400.0%$1.94
16
2024-Q3
Increased
6,143
+812.8%
$15,2960.0%$2.51
20
2024-Q2
New
673
-
$2,3560.0%$3.50
18

Other major holders of ATXI: WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used